Orphenadrine Citrate

Basic Information

View in Editor

CAS Number

4596-23-0

Molecular Formula

C24H31NO8

Molecular Weight

461.5 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Basic Physical Properties

SMILES

View in Editor

CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O

InChI

InChI=1S/C18H23NO.C6H8O7/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-12,18H,13-14H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

InChIKey

MMMNTDFSPSQXJP-UHFFFAOYSA-N

LogP

2.41412

Topological Polar Surface Area

144.60000000000002 Å²

Hydrogen Bond Donor/Acceptor

4 / 9

Complexity

488

Synonyms & References

English

ETHANAMINE, N,N-DIMETHYL-2-((2-METHYLPHENYL)PHENYLMETHOXY)-, (+/-)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
ORPHENADRINE CITRATE (EP IMPURITY)
Tox21_301079
Citrate, Orphenadrine
HMS3259M21
ORPHENADRINE CITRATE [USP MONOGRAPH]
X0A40N8I4S
Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
4682-36-4
EN300-53019
ORPHENADRINE CITRATE (EP MONOGRAPH)
CHEMBL1200395
DTXSID8044678
N,N-Dimethyl-2-(phenyl(o-tolyl)methoxy)ethanamine 2-hydroxypropane-1,2,3-tricarboxylate
SW102176-4
ORPHENADRINE CITRATE COMPONENT OF ORPHENGESIC
ORPHENADRINE CITRATE [MART.]
C75247
Q27107584
MLS000069549
NS00082653
CCG-40242
N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate
SPECTRUM1500447
CHEBI:7790
DTXCID6024678
ORPHENADRINE CITRATE [EP MONOGRAPH]
Tox21_111323
NCGC00015771-13
(+/-)-N,N-DIMETHYL-2-((O-METHYL-alpha-PHENYLBENZYL)OXY)ETHYLAMINE CITRATE (1:1)
NORGESIC COMPONENT ORPHENADRINE CITRATE

Customs Code

2922199090

FAQ

What regulatory guidelines apply to Orphenadrine Citrate (CAS: 4596-23-0)?

Orphenadrine Citrate (CAS: 4596-23-0) is regulated under the Chemicals of the Classification, Labelling, and Packaging Regulation (CLP) in the European Union. In the United States, it falls under the jurisdiction of the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA). Compliance with REACH regulations is also required for its import and use in the EU. Proper labeling and safety data sheets are essential for handling and storage.

Are there alternatives to Orphenadrine Citrate (CAS: 4596-23-0) in synthesis?

Alternatives to Orphenadrine Citrate (CAS: 4596-23-0) in synthesis include similar anticholinergic compounds like Procaine and Propantheline Bromide. For synthetic routes, isomers and analogs such as orphenadrine hydrochloride can be considered. Substitutes like benztropine mesylate and trihexyphenidyl hydrochloride can be explored based on specific needs and regulatory considerations.

What is the market or research trend for Orphenadrine Citrate (CAS: 4596-23-0)?

The market for Orphenadrine Citrate (CAS: 4596-23-0) is primarily focused on its use as an antispasmodic and anticholinergic agent. Research trends include exploring its potential in treating muscarinic receptor-mediated conditions. Demand is stable, with ongoing studies into its therapeutic applications and safety profiles. Price trends are influenced by regulatory changes and supply chain dynamics.

How should waste containing Orphenadrine Citrate (CAS: 4596-23-0) be handled?

Waste containing Orphenadrine Citrate (CAS: 4596-23-0) should be collected in appropriate containers labeled with the chemical name and hazard information. It should be disposed of through a professional waste management service that can handle hazardous chemicals. Environmental protection precautions include ensuring proper containment to prevent leakage and following local regulations for disposal.